Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Asthma

  Free Subscription


Articles published in Ann Allergy Asthma Immunol

Retrieve available abstracts of 235 articles:
HTML format



Single Articles


    February 2024
  1. AKAMATSU T, Shirai T, Okawa K, Hirai K, et al
    Improved small airway dysfunction in severe asthma with clinical remission by anti-IL-5/IL-5 receptor alpha.
    Ann Allergy Asthma Immunol. 2024 Feb 13:S1081-1206(24)00080.
    PubMed    


  2. HAN YY, Rosser F, Acosta-Perez E, Canino G, et al
    Social vulnerability index, poverty, and asthma in a prospective study of Puerto Rican youth.
    Ann Allergy Asthma Immunol. 2024 Feb 5:S1081-1206(24)00075.
    PubMed    


    January 2024
  3. BRACKEN AC, Oppenheimer JJ, Mosnaim GS, Rank MA, et al
    Simplifying asthma management in a university setting: a perspective.
    Ann Allergy Asthma Immunol. 2024 Jan 20:S1081-1206(24)00014.
    PubMed    


  4. ZHOU X, Sampath V, Nadeau KC
    Effect of Air Pollution on Asthma.
    Ann Allergy Asthma Immunol. 2024 Jan 20:S1081-1206(24)00018.
    PubMed     Abstract available


  5. ROSAS-SALAZAR C, Bacharier LB
    The biologic asthma response score: A blueprint to address biologic failure in severe asthma?
    Ann Allergy Asthma Immunol. 2024;132:7-8.
    PubMed    


  6. SHAKER M, Golden DBK
    More than 80 years of excellence and collaboration in allergy ... and just getting started.
    Ann Allergy Asthma Immunol. 2024;132:3-4.
    PubMed    


  7. LIEBERMAN JA
    Trials and tribulations of managing pediatric and adolescent asthma.
    Ann Allergy Asthma Immunol. 2024;132:1-2.
    PubMed    


    December 2023
  8. AKEL MJ, Camargo CA Jr, Fujiogi M, Hasegawa K, et al
    Lack of health disparities during implementation of hospital-initiated care bundle among hospitalized adults with asthma.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01514.
    PubMed    


  9. PEREZ-DE-LLANO L, Scelo G, Canonica GW, Chen W, et al
    Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
    Ann Allergy Asthma Immunol. 2023 Dec 25:S1081-1206(23)01508.
    PubMed     Abstract available


  10. CAMARGO CA JR, Rane PB, Beck AF, Wang Y, et al
    Geographic Variation in Disease Burden Among Patients with Severe Persistent Asthma in the United States.
    Ann Allergy Asthma Immunol. 2023 Dec 21:S1081-1206(23)01501.
    PubMed     Abstract available


  11. MOHAN A, Desai B, Lugogo N
    Analyzing Co-morbidities and their Influence on Severe Asthma: Another Missing Piece of the Puzzle Solved?
    Ann Allergy Asthma Immunol. 2023 Dec 20:S1081-1206(23)01500.
    PubMed    


  12. ADGENT MA, Buth E, Norona-Zhou A, Szpiro AA, et al
    Maternal stressful life events during pregnancy and childhood asthma and wheeze.
    Ann Allergy Asthma Immunol. 2023 Dec 18:S1081-1206(23)01498.
    PubMed     Abstract available


  13. CHU DK, Schneider L, Asiniwasis RN, Boguniewicz M, et al
    Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.
    Ann Allergy Asthma Immunol. 2023 Dec 18:S1081-1206(23)01455.
    PubMed     Abstract available


  14. ANAGNOSTOU A, Greenhawt M, Shaker M
    Improving Food Allergy Management: Control Asthma and Decrease Food Allergy Risk.
    Ann Allergy Asthma Immunol. 2023 Dec 12:S1081-1206(23)01495.
    PubMed    


  15. STEPPE S, Stokes DC, Underhill C, Winders TA, et al
    Changing High-Risk Asthma in Memphis Through Partnership: Results from the CHAMP Program.
    Ann Allergy Asthma Immunol. 2023 Dec 9:S1081-1206(23)01486.
    PubMed     Abstract available


  16. SIRCAR K, Hagen MB, Prezzato E, Hsu J, et al
    Opportunities to monitor disparities in asthma and other respiratory diseases using public health data.
    Ann Allergy Asthma Immunol. 2023;131:683-684.
    PubMed    


  17. GRAYSON MH
    Congratulations to the 2023 American College of Allergy, Asthma and Immunology Annals Fellow-in-Training award winners.
    Ann Allergy Asthma Immunol. 2023;131:681-682.
    PubMed    


    November 2023
  18. PETERS AT, Sagara H, Corren J, Domingo C, et al
    Impact of dupilumab across seasons in patients with type 2 uncontrolled, moderate-to-severe asthma.
    Ann Allergy Asthma Immunol. 2023 Nov 25:S1081-1206(23)01470.
    PubMed     Abstract available


  19. SHERENIAN M, Biagini JM, Ryan P, Hershey GKK, et al
    What allergist/immunologists can do to limit the effects of air pollution on asthma and allergies.
    Ann Allergy Asthma Immunol. 2023 Nov 24:S1081-1206(23)01468.
    PubMed    


  20. YANG Y, Kimura H, Yokota I, Makita H, et al
    Applicable predictive factors extracted from peak flow trajectory for the prediction of asthma exacerbation.
    Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01464.
    PubMed     Abstract available


  21. COREY KB, Moore R, Zuckerman AD, Littlejohn M, et al
    Persistent use of dupilumab in adults with asthma or chronic rhinosinusitis with nasal polyps.
    Ann Allergy Asthma Immunol. 2023 Nov 17:S1081-1206(23)01454.
    PubMed    


  22. PHAM DD, Lee JH, Kwon HS, Song WJ, et al
    Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.
    Ann Allergy Asthma Immunol. 2023 Nov 15:S1081-1206(23)01402.
    PubMed     Abstract available


  23. BLAISS M, Bleecker ER, Jacob-Nara J, Nair R, et al
    Real-world effectiveness of dupilumab in patients with asthma: findings from the United States ADVANTAGE study.
    Ann Allergy Asthma Immunol. 2023 Nov 13:S1081-1206(23)01399.
    PubMed     Abstract available


  24. AGARWAL CD, Palka JM, Gajewski AJ, Khan DA, et al
    The Efficacy of Citalopram or Escitalopram in Patients with Asthma and Major Depressive Disorder.
    Ann Allergy Asthma Immunol. 2023 Nov 10:S1081-1206(23)01401.
    PubMed     Abstract available


  25. CHEN M, Bacong AM, Feng C, Kikuta NT, et al
    Asthma heterogeneity amongst Asian American children: the California Health Interview Survey.
    Ann Allergy Asthma Immunol. 2023 Nov 8:S1081-1206(23)01395.
    PubMed     Abstract available


  26. XU J, Rathkopf MM
    The cost of medication costs: Cost-related medication nonadherence in patients with asthma in the United States.
    Ann Allergy Asthma Immunol. 2023;131:538-539.
    PubMed    


    October 2023
  27. PATEL D, Revier MD, Tambay A, Geng B, et al
    Implementation of a Pediatric Synchronous Multidisciplinary Severe Asthma Clinic and Real-World Outcomes.
    Ann Allergy Asthma Immunol. 2023 Oct 26:S1081-1206(23)01380.
    PubMed    


  28. HO JK, Shaker M, Greenhawt M, Sadatsafavi M, et al
    Cost-effectiveness of budesonide-formoterol versus inhaled epinephrine in United States adults with mild asthma.
    Ann Allergy Asthma Immunol. 2023 Oct 23:S1081-1206(23)01352.
    PubMed     Abstract available


  29. JOHNSON KM, Cheng L, Yin Y, Carter R, et al
    Impact of income-based public drug coverage deductibles on adherence to asthma medications.
    Ann Allergy Asthma Immunol. 2023 Oct 21:S1081-1206(23)01345.
    PubMed     Abstract available


  30. YOSHIZATO R, Motomura Y, Fujita T, Babazono A, et al
    Secondhand smoking and pediatric asthma after respiratory syncytial virus or human metapneumovirus infection.
    Ann Allergy Asthma Immunol. 2023 Oct 18:S1081-1206(23)01342.
    PubMed    


  31. KILPATRICK K, Ambrose CS, Lindsley AW, Oppenheimer J, et al
    At-Home Asthma Mortality Unchanged Despite Declining Mortality in Other Settings: US Death Certificate Data (2000-2019).
    Ann Allergy Asthma Immunol. 2023 Oct 15:S1081-1206(23)01315.
    PubMed     Abstract available


  32. CHAN R, Lipworth B
    Characterising moderate-to-severe asthma patients with preserved small airway function.
    Ann Allergy Asthma Immunol. 2023 Oct 10:S1081-1206(23)01306.
    PubMed    


  33. AVERILL SH, Forno E
    Management of the Pediatric Patient with Asthma and Obesity.
    Ann Allergy Asthma Immunol. 2023 Oct 10:S1081-1206(23)01301.
    PubMed     Abstract available


  34. SHAKER M, Abrams EM, Sublett JW
    Corrigendum to "Contextual community epinephrine prescribing: Is more always better?" [Ann Allergy Asthma Immunol 131 (2023) 176-184].
    Ann Allergy Asthma Immunol. 2023;131:534.
    PubMed    


  35. COSCIA G
    Asthma control questionnaires: A broader perspective.
    Ann Allergy Asthma Immunol. 2023;131:405-406.
    PubMed    


  36. HERZBERG SD, Bosso AM, Sangal NR, Bosso JV, et al
    Eosinophilic granulomatosis with polyangiitis presenting as aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2023;131:528-530.
    PubMed    


    September 2023
  37. BLAISS M, Oppenheimer J, Corbett M, Bacharier L, et al
    Consensus of an ACAAI, AAAAI, and ATS Workgroup on Definition of Clinical Remission in Asthma on Treatment.
    Ann Allergy Asthma Immunol. 2023 Sep 8:S1081-1206(23)01218.
    PubMed    


  38. GRAYSON MH, Williams PV
    Defining remission in asthma care.
    Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01217.
    PubMed    


  39. HUNT KM, Foley M, Connors LA, Hildebrand KJ, et al
    Trends in the Proportion of Women Speakers at North American Allergy & Immunology Conferences, 2008-2020.
    Ann Allergy Asthma Immunol. 2023 Sep 7:S1081-1206(23)01215.
    PubMed     Abstract available


  40. KIM SL, Rank MA, Peters AT
    The chronic rhinosinusitis practice parameter.
    Ann Allergy Asthma Immunol. 2023;131:307-310.
    PubMed     Abstract available


  41. SUPRON AD, Bergmark RW, Roditi RE, Buchheit KM, et al
    Perioperative mepolizumab in aspirin-exacerbated respiratory disease does not prevent nasal polyp regrowth.
    Ann Allergy Asthma Immunol. 2023;131:384-386.
    PubMed    


  42. RAMOS CL, Thakrar H, Walters K, Waldram J, et al
    Characterization of alcohol-induced respiratory symptoms in aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2023;131:382-384.
    PubMed    


  43. MULLUR J, Buchheit KM
    Aspirin-exacerbated respiratory disease: Updates in the era of biologics.
    Ann Allergy Asthma Immunol. 2023;131:317-324.
    PubMed     Abstract available


  44. NAEGER S, Macina D, Pool V
    Tetanus, diphtheria, and acellular pertussis vaccine coverage in adults with chronic respiratory conditions.
    Ann Allergy Asthma Immunol. 2023;131:333-337.
    PubMed     Abstract available


    August 2023
  45. SCHEPEL IRM, Banzon TM, Phipatanakul W
    Future of Biologics in Pediatric Asthma: Optimizing Response, Early Introduction, and Equitable Access to Treatment.
    Ann Allergy Asthma Immunol. 2023 Aug 29:S1081-1206(23)01207.
    PubMed     Abstract available


  46. PERSAUD PN, Tran AP, Messner D, Thornton JD, et al
    Perception of burden of oral and inhaled corticosteroid adverse effects on asthma-specific quality of life.
    Ann Allergy Asthma Immunol. 2023 Aug 27:S1081-1206(23)00636.
    PubMed     Abstract available


  47. SCELO G, Torres-Duque CA, Maspero J, Tran TN, et al
    Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
    Ann Allergy Asthma Immunol. 2023 Aug 26:S1081-1206(23)00630.
    PubMed     Abstract available


  48. GALANT SP, Morphew T
    Adding oscillometry to spirometry in guidelines better identifies uncontrolled asthma, future exacerbations, potential targeted therapy.
    Ann Allergy Asthma Immunol. 2023 Aug 23:S1081-1206(23)00587.
    PubMed     Abstract available


  49. PAVORD ID, Hoyte FCL, Lindsley AW, Ambrose CS, et al
    Tezepelumab reduces exacerbations across all seasons in patients with severe, uncontrolled asthma (NAVIGATOR).
    Ann Allergy Asthma Immunol. 2023 Aug 22:S1081-1206(23)00593.
    PubMed     Abstract available


  50. GAFFNEY A, Himmelstein DU, Woolhandler S
    Population-Level Trends in Asthma and COPD Emergency Department Visits and Hospitalizations Before and During the COVID-19 Pandemic in the US.
    Ann Allergy Asthma Immunol. 2023 Aug 22:S1081-1206(23)00591.
    PubMed     Abstract available


  51. HUI-BECKMAN J, Goleva E, Leung DYM, Kim BE, et al
    The impact of temperature on the skin barrier and atopic dermatitis.
    Ann Allergy Asthma Immunol. 2023 Aug 16:S1081-1206(23)00569.
    PubMed     Abstract available


  52. WISNIVESKY JP, Agrawal N, Ankam J, Gonzalez A, et al
    World Trade Center Workers with Asthma and PTSD More Accurately Perceive Airflow Limitation.
    Ann Allergy Asthma Immunol. 2023 Aug 12:S1081-1206(23)00568.
    PubMed     Abstract available


  53. KAYSER MZ, Julicher BL, Welte T, Fuge J, et al
    Retrospective Analysis and Biologic Asthma Response Score reveal roadmap for switching biologics in severe asthma.
    Ann Allergy Asthma Immunol. 2023 Aug 12:S1081-1206(23)00567.
    PubMed    


  54. AVDEEV SN, Gaynitdinova VV, Pozdnakova AA, Yu Chikina S, et al
    Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up.
    Ann Allergy Asthma Immunol. 2023 Aug 7:S1081-1206(23)00564.
    PubMed    


  55. HSU CS, Chen YM, Hsu CY, Deng YL, et al
    Diabetes Mellitus and Bone Mineral Density on Fracture Risk in Allergic Rhinitis and Asthma Patients.
    Ann Allergy Asthma Immunol. 2023 Aug 7:S1081-1206(23)00565.
    PubMed    


  56. KOENIGSBERG R, Grayson MH
    Did the coronavirus disease 2019 pandemic change asthma prevalence?
    Ann Allergy Asthma Immunol. 2023;131:141-142.
    PubMed    


    July 2023
  57. CHAN R, Lipworth B
    Real life effects of dupilumab on airway oscillometry in severe uncontrolled asthma.
    Ann Allergy Asthma Immunol. 2023 Jul 28:S1081-1206(23)00558.
    PubMed    


  58. LEDFORD DK, Soong W, Carr W, Trevor J, et al
    Real-world Severe Asthma Biologic Administration and Adherence Differs by Biologic: CHRONICLE Study Results.
    Ann Allergy Asthma Immunol. 2023 Jul 26:S1081-1206(23)00522.
    PubMed     Abstract available


  59. XIA T, Qiu H, Yu B, Bi J, et al
    Cost-Related Medication Nonadherence In U.S. Adults With Asthma: The National Health Interview Survey 2013-2020.
    Ann Allergy Asthma Immunol. 2023 Jul 25:S1081-1206(23)00518.
    PubMed     Abstract available


  60. UGALDE IC, Ratigan A, Merriman C, Cui J, et al
    Preference for and Impact of Telehealth vs. In-person Asthma Visits Among Black and Latinx Adults.
    Ann Allergy Asthma Immunol. 2023 Jul 23:S1081-1206(23)00520.
    PubMed     Abstract available


  61. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
    An asthma phenotype comprising bronchial wall thickening and mucus plugging confers worse clinical outcomes.
    Ann Allergy Asthma Immunol. 2023 Jul 18:S1081-1206(23)00500.
    PubMed    


  62. MOSNAIM G
    Can we improve adherence and asthma outcomes in children and adolescents with technology-based interventions?
    Ann Allergy Asthma Immunol. 2023 Jul 9:S1081-1206(23)00493.
    PubMed    


  63. ZAEH SE, Chupp G, Eakin MN
    Is there a Best Strategy to Prevent Asthma Exacerbations in Inner City Asthmatics?
    Ann Allergy Asthma Immunol. 2023 Jul 9:S1081-1206(23)00492.
    PubMed    


  64. LAU HX, Chen Z, Bever HV, Tham EH, et al
    Clinical predictors of wheeze trajectories and associations with allergy in Asian children.
    Ann Allergy Asthma Immunol. 2023 Jul 5:S1081-1206(23)00485.
    PubMed     Abstract available


  65. SANTIAGO DVH, Fagbamigbe DAF, Sullivan PF, Agrawal DU, et al
    Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study.
    Ann Allergy Asthma Immunol. 2023 Jul 4:S1081-1206(23)00487.
    PubMed     Abstract available


  66. BELLANTI JA, Schroer B, Marshall GD Jr, Grayson MH, et al
    The 80th anniversary of Annals of Allergy, Asthma & Immunology (1943-2023).
    Ann Allergy Asthma Immunol. 2023;131:128-130.
    PubMed     Abstract available


  67. MENDOZA J, Carlson G, Nath P, Quinn J, et al
    A look at adherence with subcutaneous immunotherapy without out-of-pocket patient costs.
    Ann Allergy Asthma Immunol. 2023;131:96-100.
    PubMed     Abstract available


    June 2023
  68. LANZ MJ, Gilbert IA, Gandhi HN, Pollack M, et al
    Patterns of rescue and maintenance therapy claims surrounding a clinical encounter for an asthma exacerbation.
    Ann Allergy Asthma Immunol. 2023 Jun 19:S1081-1206(23)00441.
    PubMed     Abstract available


  69. LARENAS-LINNEMANN D, Romeo J, Ariue B, Oppenheimer J, et al
    ACAAI members' preferred step 1-3 asthma maintenance and reliever therapy and incomplete insurance coverage indicated as main practice hurdle.
    Ann Allergy Asthma Immunol. 2023 Jun 14:S1081-1206(23)00407.
    PubMed     Abstract available


  70. KIM I, Morphew T, Chou C, Ehwerhemuepha L, et al
    Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children.
    Ann Allergy Asthma Immunol. 2023 Jun 13:S1081-1206(23)00417.
    PubMed    


  71. LEE E, Rhee EH, Kim K, Kim HS, et al
    Frequency of exacerbation and degree of required asthma medication can characterize childhood longitudinal asthma trajectories.
    Ann Allergy Asthma Immunol. 2023 Jun 9:S1081-1206(23)00408.
    PubMed     Abstract available


  72. NGUYEN AT, Settipane RA
    Erratum to "A potpourri of summer allergic environmental disorders" [Ann Allergy Asthma Immunol 130 (2023) 415-418].
    Ann Allergy Asthma Immunol. 2023;130:823.
    PubMed    


    May 2023
  73. PHAM DD, Lee JH, Kwon HS, Song WJ, et al
    Prospective direct comparison of biological treatments on severe eosinophilic asthma: Findings from the PRISM study.
    Ann Allergy Asthma Immunol. 2023 May 31:S1081-1206(23)00402.
    PubMed     Abstract available


  74. EKSTEDT S, Lagebro V, Georen SK, Cardell LO, et al
    Prolonged inflammatory resolution in allergic asthma relates to dysfunctional interactions between neutrophils and airway epithelium.
    Ann Allergy Asthma Immunol. 2023 May 31:S1081-1206(23)00400.
    PubMed     Abstract available


  75. MENZIES-GOW A, Bourdin A, Chupp G, Israel E, et al
    Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma: the NAVIGATOR study.
    Ann Allergy Asthma Immunol. 2023 May 30:S1081-1206(23)00399.
    PubMed     Abstract available


  76. DEBNATH C, Agarwal S, Atkinson C, Chong LK, et al
    Impact of Race on In-Hospital Outcomes of Patients Hospitalized for Asthma Exacerbation.
    Ann Allergy Asthma Immunol. 2023 May 30:S1081-1206(23)00397.
    PubMed    


  77. NAZARIO S, Gonzalez-Sepulveda L, Telon-Sosa B, Rivas-Tumanyan S, et al
    Place of death from asthma differs by age, race and ethnicity.
    Ann Allergy Asthma Immunol. 2023 May 22:S1081-1206(23)00359.
    PubMed    


  78. WOO SD, Park HS, Jang JH, Lee Y, et al
    Biomarkers for Predicting Type 2-high and Uncontrolled Asthma in Real-World Practice.
    Ann Allergy Asthma Immunol. 2023 May 18:S1081-1206(23)00339.
    PubMed     Abstract available


  79. CHAN R, Lipworth B
    Clinical impact of obesity on oscillometry lung mechanics in adult asthmatics.
    Ann Allergy Asthma Immunol. 2023 May 18:S1081-1206(23)00341.
    PubMed     Abstract available


  80. BEDOLLA-BARAJAS M, Morales-Romero J, Robles-Figueroa M, Delgado-Figueroa T, et al
    Changes in the national prevalence of asthma and COVID-19 fatality: A population-based cross-sectional study.
    Ann Allergy Asthma Immunol. 2023 May 2:S1081-1206(23)00327.
    PubMed     Abstract available


  81. HANTGAN SL, Jariwala SP
    Erratum to "User-centered mobile health applications for asthma" [Ann Allergy Asthma Immunol 130 (2023) 159-160].
    Ann Allergy Asthma Immunol. 2023;130:692.
    PubMed    


  82. GOLDSOBEL AB
    Corrigendum to "Chronic cough comes of age" [Ann Allergy Asthma Immunol 130 (2023) Pages 4-5].
    Ann Allergy Asthma Immunol. 2023;130:692.
    PubMed    


  83. GALANT SP
    Could salivary alpha-amylase be a proxy for identifying beta-2 adrenergic induced tolerization in asthma?
    Ann Allergy Asthma Immunol. 2023;130:544-545.
    PubMed    


  84. STROTHMAN K
    Choosing biologics for uncontrolled asthma: A conundrum for clinicians.
    Ann Allergy Asthma Immunol. 2023;130:534-535.
    PubMed    


    April 2023
  85. LUCAS D, Gourier G, Bygvraa DA, Canals ML, et al
    Occupational allergic diseases among harvesting fishermen at the open sea: a systematic review.
    Ann Allergy Asthma Immunol. 2023 Apr 26:S1081-1206(23)00285.
    PubMed     Abstract available


  86. CHIPPS B, Zeiger RS, Beuther DA, Reibman J, et al
    The Asthma Impairment and Risk Questionnaire Enhances the Assessment of Asthma Control.
    Ann Allergy Asthma Immunol. 2023 Apr 25:S1081-1206(23)00308.
    PubMed     Abstract available


  87. SHEEHAN WJ, Maghzian N, Rastogi D, Bollard CM, et al
    Decreased Regulatory B Cells in Pediatric Patients with Asthma.
    Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00306.
    PubMed    


  88. ITO K, Kanemitsu Y, Fukumitsu K, Tajiri T, et al
    Targeting the IL-5 pathway improves cough hypersensitivity in patients with severe uncontrolled asthma.
    Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00310.
    PubMed     Abstract available


  89. LEE JH, Hong C, Oh JS, Kim TB, et al
    Electronic Medical Record-Based Machine Learning Predicts the Relapse of Asthma Exacerbation.
    Ann Allergy Asthma Immunol. 2023 Apr 24:S1081-1206(23)00307.
    PubMed    


  90. HONG B, Merrill KA, Golding MA, Simons E, et al
    Pre-hospital epinephrine administration for treating anaphylaxis among those with co-morbid asthma: A scoping review.
    Ann Allergy Asthma Immunol. 2023 Apr 21:S1081-1206(23)00267.
    PubMed     Abstract available


  91. SHANNON CM, Flaherty C, Quarshie WO, Xiao R, et al
    Asthma medication adherence during the COVID-19 pandemic in children at high risk of exacerbation.
    Ann Allergy Asthma Immunol. 2023 Apr 18:S1081-1206(23)00263.
    PubMed    


  92. FUKUMITSU K, Kanemitsu Y, Kurokawa R, Takeda N, et al
    Tiotropium for refractory cough in asthma via cough reflex sensitivity: a randomized, parallel, open-label, trial.
    Ann Allergy Asthma Immunol. 2023 Apr 6:S1081-1206(23)00248.
    PubMed     Abstract available


  93. TEAGUE WG
    Analysis of lung lavage granulocyte constituents and blood type 2 biomarkers does not support routine use of corticosteroids in children with problematic wheeze: Reply to: Short courses of oral corticosteroids are effective, important, and safe for vi
    Ann Allergy Asthma Immunol. 2023;130:526.
    PubMed    


  94. WEINBERGER M
    Short courses of oral corticosteroids are effective, important, and safe for virus-triggered wheeze.
    Ann Allergy Asthma Immunol. 2023;130:525.
    PubMed    


    March 2023
  95. LEE E, Park YM, Lee SY, Lee SH, et al
    Associations of prenatal antibiotic exposure and delivery mode on childhood asthma inception.
    Ann Allergy Asthma Immunol. 2023 Mar 27:S1081-1206(23)00208.
    PubMed     Abstract available


  96. REDDY A, Dunivin G, Garlapati R, Reddy S, et al
    Readability and quality of patient education material for asthma.
    Ann Allergy Asthma Immunol. 2023 Mar 27:S1081-1206(23)00209.
    PubMed    


  97. ALI H, Douwes J, Burmanje J, Gokhale P, et al
    Sputum inflammatory, neural, and remodelling mediators in eosinophilic and non-eosinophilic asthma.
    Ann Allergy Asthma Immunol. 2023 Mar 21:S1081-1206(23)00181.
    PubMed     Abstract available


  98. JACKSON DJ, Bacharier LB, Phipatanakul W, Sher L, et al
    Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma.
    Ann Allergy Asthma Immunol. 2023 Mar 21:S1081-1206(23)00180.
    PubMed     Abstract available


  99. HORN A, Bernstein DI, Okubo K, Dalgaard T, et al
    House Dust Mite Sublingual Immunotherapy Tablet Safety in Adolescents with Allergic Rhinoconjunctivitis: Clinical Trial Results.
    Ann Allergy Asthma Immunol. 2023 Mar 14:S1081-1206(23)00171.
    PubMed     Abstract available


  100. CHIPPS BE, Soong W, Panettieri RA Jr, Carr W, et al
    Number of patient-reported asthma triggers predicts uncontrolled disease among specialist-treated patients with severe asthma.
    Ann Allergy Asthma Immunol. 2023 Mar 9:S1081-1206(23)00165.
    PubMed     Abstract available


  101. GUTWEIN A, Han YY, Colon-Semidey A, Alvarez M, et al
    Low parental numeracy and severe asthma exacerbations in a prospective study of Puerto Rican youth.
    Ann Allergy Asthma Immunol. 2023 Mar 7:S1081-1206(23)00166.
    PubMed     Abstract available


  102. VOLERMAN A, Balachandran U, Zhu M, Akel M, et al
    Evaluating Inhaler Education Interventions for Hospitalized Children with Asthma: A Randomized Controlled Trial.
    Ann Allergy Asthma Immunol. 2023 Mar 2:S1081-1206(23)00131.
    PubMed     Abstract available


  103. ACEVES SS, Dellon ES, Greenhawt M, Hirano I, et al
    Clinical guidance for the use of dupilumab in eosinophilic esophagitis: A yardstick.
    Ann Allergy Asthma Immunol. 2023;130:371-378.
    PubMed     Abstract available


    February 2023
  104. CHAN R, Lipworth B
    Efficacy of biologic therapy on airway hyperresponsiveness in asthma.
    Ann Allergy Asthma Immunol. 2023 Feb 23:S1081-1206(23)00121.
    PubMed     Abstract available


  105. LEDFORD DK
    Self-Contained Underwater Breathing Apparatus (SCUBA) Diving and Asthma: Where are we in 2023?
    Ann Allergy Asthma Immunol. 2023 Feb 17:S1081-1206(23)00046.
    PubMed     Abstract available


  106. STICKLER MB, Hamilton RG, Cooke RK, Bollinger ME, et al
    An emerging new respiratory pathogen, Lophomonas blattarum, found in bronchoalveolar lavage in an immunodeficient patient with asthma.
    Ann Allergy Asthma Immunol. 2023 Feb 13:S1081-1206(23)00091.
    PubMed    


  107. KAMAN K, Dhodapkar M, Shabanova V, McCollum S, et al
    Validated Anxiety Assessments Among Pediatric Peanut-Allergic Patients on Oral Immunotherapy.
    Ann Allergy Asthma Immunol. 2023 Feb 2:S1081-1206(23)00080.
    PubMed     Abstract available


  108. PANDYA A, Portnoy J
    Does improved indoor air quality lead to better asthma control?
    Ann Allergy Asthma Immunol. 2023;130:147-148.
    PubMed    


  109. BORISH L, Teague WG, Patrie JT, Wavell KW, et al
    Further evidence of a type 2 inflammatory signature in chronic obstructive pulmonary disease or emphysema.
    Ann Allergy Asthma Immunol. 2023 Feb 1:S1081-1206(23)00078.
    PubMed     Abstract available


    January 2023
  110. HOLLENBACH JP, Collins MS, Wasser C, Fedele D, et al
    Implementation of standardized asthma management programs in outpatient settings.
    Ann Allergy Asthma Immunol. 2023 Jan 23:S1081-1206(23)00041.
    PubMed     Abstract available


  111. OPPENHEIMER J, Borish L
    Operationalization of Dynamic Dosing in Asthma.
    Ann Allergy Asthma Immunol. 2023 Jan 17:S1081-1206(23)00008.
    PubMed    


  112. SUZUKAWA M, Ohta K, Hashimoto H, Oyamada Y, et al
    Characterization and cluster analyses of elderly asthma in comparison with non-elderly asthma patients in Japan.
    Ann Allergy Asthma Immunol. 2023 Jan 16:S1081-1206(23)00005.
    PubMed     Abstract available


  113. GALANT SP, Morphew T
    IN YOUNG ASTHMATIC CHILDREN, OBESITY AND UNCONTROLLED DISEASE ARE HIGHLY ASSOCIATED WITH PERIPHERAL AIRWAY IMPAIRMENT.
    Ann Allergy Asthma Immunol. 2023 Jan 13:S1081-1206(23)00004.
    PubMed     Abstract available


  114. GOLDSOBEL AB
    Chronic cough comes of age.
    Ann Allergy Asthma Immunol. 2023;130:4-5.
    PubMed    


  115. NEAVES BI, Adams KE, White KM, Stokes SC, et al
    Long-term adherence to imported fire ant subcutaneous immunotherapy.
    Ann Allergy Asthma Immunol. 2023;130:106-110.
    PubMed     Abstract available


    December 2022
  116. PITRE T, Jassal T, Angjeli A, Jarabana V, et al
    A comparison of the effectiveness of biologic therapies for asthma:a systematic review and network meta-analysis.
    Ann Allergy Asthma Immunol. 2022 Dec 20:S1081-1206(22)02000.
    PubMed     Abstract available


  117. CORBETT M, Allen A, Bobo N, Foggs MB, et al
    Proceedings of a Roundtable Conducted by the American College of Allergy, Asthma & Immunology on Racial Disparities in Atopic Dermatitis and Food Allergy.
    Ann Allergy Asthma Immunol. 2022 Dec 17:S1081-1206(22)02001.
    PubMed     Abstract available


  118. CHEN JH, Orden T, Wang J, Sowho M, et al
    Risk of anaphylaxis in cluster versus standard subcutaneous multi-allergen immunotherapy.
    Ann Allergy Asthma Immunol. 2022 Dec 12:S1081-1206(22)01993.
    PubMed     Abstract available


  119. CHAN R, Lipworth B
    Severe asthma with fungal sensitisation is associated with worse small airways dysfunction but similar symptom control.
    Ann Allergy Asthma Immunol. 2022 Dec 10:S1081-1206(22)01987.
    PubMed    


  120. SHER LD, Passalacqua G, Taille C, Cohn L, et al
    Long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma.
    Ann Allergy Asthma Immunol. 2022 Dec 9:S1081-1206(22)01983.
    PubMed     Abstract available


  121. INSELMAN JW, Jeffery MM, Maddux JT, Lam RW, et al
    A prediction model for asthma exacerbations after stopping asthma biologics.
    Ann Allergy Asthma Immunol. 2022 Dec 9:S1081-1206(22)01972.
    PubMed     Abstract available


  122. CHAN R, Duraikannu C, Lipworth B
    Clinical characteristics of the asthma bronchiectasis phenotype.
    Ann Allergy Asthma Immunol. 2022 Dec 8:S1081-1206(22)01984.
    PubMed    


  123. MAKIN T, Breidenbaugh M, Borish L
    Novel insights into pathogenic mechanisms of severe exacerbation-prone asthma and their impact on clinical management.
    Ann Allergy Asthma Immunol. 2022;129:651-652.
    PubMed    


  124. GRAYSON MH
    Announcing the 2022 American College of Allergy, Asthma and Immunology Annals fellow-in-training award winners.
    Ann Allergy Asthma Immunol. 2022;129:649-650.
    PubMed    


  125. TEAGUE WG
    Lung lavage inflammatory patterns and pathogen profiles in preschool children with problematic wheeze.
    Ann Allergy Asthma Immunol. 2022;129:674-675.
    PubMed    


    November 2022
  126. KHAN DA
    The best of 2022 American College of Allergy, Asthma, and Immunology literature review.
    Ann Allergy Asthma Immunol. 2022 Nov 29:S1081-1206(22)01901.
    PubMed    


  127. LI C, Zhang B, Yan M, Li Y, et al
    Cluster Analysis of Patients with Chronic Rhinosinusitis and Asthma after Endoscopic Sinus Surgery.
    Ann Allergy Asthma Immunol. 2022 Nov 24:S1081-1206(22)01955.
    PubMed     Abstract available


  128. RIEDL MA
    Update on skin diseases: Urticaria, angioedema, and other skin disorders from the 2022 American College of Allergy, Asthma, and Immunology Annual Literature Review.
    Ann Allergy Asthma Immunol. 2022 Nov 23:S1081-1206(22)01913.
    PubMed    


  129. HANTGAN SL, Jariwala SP
    User-centered mobile health applications for asthma.
    Ann Allergy Asthma Immunol. 2022 Nov 15. pii: S1081-1206(22)01917.
    PubMed    


  130. ZHANG X, Xu Z, Lin J, Xie G, et al
    Sex differences of small airway function and FeNO in patients with mild asthma.
    Ann Allergy Asthma Immunol. 2022 Nov 15. pii: S1081-1206(22)01916.
    PubMed     Abstract available


  131. BERGER P, Menzies-Gow A, Peters AT, Kuna P, et al
    Long-term efficacy of dupilumab in asthma with and without chronic rhinosinusitis and/or nasal polyps.
    Ann Allergy Asthma Immunol. 2022 Nov 7. pii: S1081-1206(22)01912.
    PubMed     Abstract available


  132. GREINER B, Cronin K, Salazar L, Hartwell M, et al
    Asthma related disparities in emergency department usage and clinical outcomes among Spanish speaking Hispanic patients.
    Ann Allergy Asthma Immunol. 2022 Nov 7. pii: S1081-1206(22)01909.
    PubMed    


  133. HANANIA NA, Castro M, Bateman E, Pavord ID, et al
    Efficacy of Dupilumab in Patients with Moderate-to-Severe Asthma and Persistent Airflow Obstruction.
    Ann Allergy Asthma Immunol. 2022 Nov 1. pii: S1081-1206(22)01899.
    PubMed     Abstract available


  134. GHIASI Y, Wangberg H, Bagsic SRS, White A, et al
    Type 2 biologics reduce cumulative steroid exposure in aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2022;129:642-643.
    PubMed    


    October 2022
  135. FONG WCG, Kadalayil L, Lowther S, Grevatt S, et al
    Efficacy of Dyson air purifier on asthma control: a single-center, investigator-led, randomized, double-blind, placebo-controlled trial.
    Ann Allergy Asthma Immunol. 2022 Oct 23. pii: S1081-1206(22)01850.
    PubMed     Abstract available


  136. MCCULLOCH MR, Thomas JF, Thompson MA, Carel KD, et al
    Outpatient Electronic Consultations in Pediatric Allergy/Immunology.
    Ann Allergy Asthma Immunol. 2022 Oct 8. pii: S1081-1206(22)01827.
    PubMed    


  137. LI JT
    Asthma chronic obstructive pulmonary disease and lower respiratory disorders.
    Ann Allergy Asthma Immunol. 2022 Oct 6:S1081-1206(22)01727.
    PubMed    


  138. WEINBERGER M
    Can current hospitalization rates for asthma be decreased?
    Ann Allergy Asthma Immunol. 2022;129:401-402.
    PubMed    


  139. WEINBERGER M
    Should asthma evaluation include assessment of small airway function?
    Ann Allergy Asthma Immunol. 2022;129:399-400.
    PubMed    


  140. COLAK Y, Ingebrigtsen TS, Nordestgaard BG, Marott JL, et al
    Plasma immunoglobulin E and risk of exacerbation and mortality in chronic obstructive pulmonary disease: A contemporary population-based cohort.
    Ann Allergy Asthma Immunol. 2022;129:490-496.
    PubMed     Abstract available


    September 2022
  141. CHAN R, Stewart K, Lipworth B
    Airflow obstruction in real life is associated with small airways dysfunction in moderate to severe asthma.
    Ann Allergy Asthma Immunol. 2022 Sep 24. pii: S1081-1206(22)01775.
    PubMed    


  142. SANGKANJANAVANICH S, Pradubpongsa P, Mitthamsiri W, Sangasapaviliya A, et al
    Bifidobacterium infantis 35624 Efficacy in Patients with Uncontrolled Asthma: A Randomized Placebo-Controlled Trial.
    Ann Allergy Asthma Immunol. 2022 Sep 8. pii: S1081-1206(22)01712.
    PubMed    


    August 2022
  143. BIGGS SE, Ownby DR, May KR
    Use of over-the-counter inhaled epinephrine in asthma.
    Ann Allergy Asthma Immunol. 2022 Aug 27. pii: S1081-1206(22)01674.
    PubMed    


  144. PRICE AS, Kennedy JL
    T helper 2 Mechanisms involved in Human Rhinovirus Infections and Asthma.
    Ann Allergy Asthma Immunol. 2022 Aug 21. pii: S1081-1206(22)00695.
    PubMed     Abstract available


  145. LIU J, Yuan MB, Chen YQ, Wang Y, et al
    Global burden of asthma associated with high body mass index from 1990 to 2019.
    Ann Allergy Asthma Immunol. 2022 Aug 21. pii: S1081-1206(22)00694.
    PubMed     Abstract available


  146. CHOW TG, Palka JM, Stone B, Trojan T, et al
    Safety of Subcutaneous Immunotherapy in Patients with Severe Asthma.
    Ann Allergy Asthma Immunol. 2022 Aug 20. pii: S1081-1206(22)00693.
    PubMed     Abstract available


  147. COLETTA C, Grayson MH
    Causation or coincidence? Phenotype of asthma exacerbations during the coronavirus disease 2019 pandemic.
    Ann Allergy Asthma Immunol. 2022;129:131-132.
    PubMed    


    July 2022
  148. BRYANT N, Muehling LM
    T-cell responses in asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jul 30. pii: S1081-1206(22)00621.
    PubMed     Abstract available


  149. IMAM SF, Zafar S, Oppenheimer J
    SMART in treatment of asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jul 29. pii: S1081-1206(22)00619.
    PubMed     Abstract available


  150. GREINER B, Hartwell M
    Prevalence and associations between metabolically unhealthy obesity and asthma exacerbations and emergency department usage.
    Ann Allergy Asthma Immunol. 2022 Jul 14. pii: S1081-1206(22)00590.
    PubMed     Abstract available


  151. PATE CA, Zahran HS, Malilay J, Hsu J, et al
    The Shifting Prevalence of Asthma and Allergic Disease in United States Children.
    Ann Allergy Asthma Immunol. 2022 Jul 13. pii: S1081-1206(22)00586.
    PubMed     Abstract available


    June 2022
  152. LEE TY, Petkau J, Mangat N, Safari A, et al
    16-year trends in asthma hospital admissions in Canada.
    Ann Allergy Asthma Immunol. 2022 Jun 29. pii: S1081-1206(22)00540.
    PubMed     Abstract available


  153. DINWIDDIE DL, Kaukis N, Pham S, Hardin O, et al
    Viral infection and allergy status impact severity of asthma symptoms in children with asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Jun 21. pii: S1081-1206(22)00535.
    PubMed     Abstract available


  154. PANETTIERI RA JR, Ledford DK, Chipps BE, Soong W, et al
    Biologic Use and Outcomes Among Adults with Severe Asthma Treated by United States Subspecialists.
    Ann Allergy Asthma Immunol. 2022 Jun 18. pii: S1081-1206(22)00532.
    PubMed     Abstract available


  155. POLIVKA BJ, Huntington-Moskos L, Antimisiaris DE, Cavallazzi RS, et al
    Phenotyping Older Adults with Asthma via Cluster Analysis.
    Ann Allergy Asthma Immunol. 2022 Jun 10. pii: S1081-1206(22)00501.
    PubMed    


  156. RURAN HB, Maciag MC, Murphy SE, Phipatanakul W, et al
    Cross-Sectional Study of Urinary Biomarkers of Environmental Tobacco and E-Cigarette Exposure and Asthma Morbidity.
    Ann Allergy Asthma Immunol. 2022 Jun 7. pii: S1081-1206(22)00499.
    PubMed    


  157. BELLANTI JA, Lanier BQ, Ein D, Finegold I, et al
    The American College of Allergy, Asthma & Immunology: an 80-year legacy of accomplishments (1942-2022), part 3: events and achievements (2012-2022).
    Ann Allergy Asthma Immunol. 2022 Jun 4. pii: S1081-1206(22)00494.
    PubMed    


  158. CHUNG Y, Katial R, Mu F, Cook EE, et al
    Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 Study.
    Ann Allergy Asthma Immunol. 2022;128:669-676.
    PubMed     Abstract available


    May 2022
  159. SCIOSCIA BG, Lacedonia D, Quarato CMI, Tondo P, et al
    Could Transthoracic Ultrasound be useful to suggest a small airways disease in severe uncontrolled asthma?
    Ann Allergy Asthma Immunol. 2022 May 25. pii: S1081-1206(22)00491.
    PubMed     Abstract available


  160. CHUPP G, Wechsler ME
    Biologic Medications in Asthma: What have we learned from long-term studies?
    Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00489.
    PubMed    


  161. WANG EA, Goleva E, Ketosugbo K, Kern JA, et al
    Effect of immune checkpoint inhibitors on asthma.
    Ann Allergy Asthma Immunol. 2022 May 24. pii: S1081-1206(22)00487.
    PubMed    


  162. LIPWORTH DB, Stewart MK, Chan DR
    Pragmatic reappraisal of long acting muscarinic antagonists at steps 4/5 for persistent adult asthma: Invited Perspective article for Annals of Allergy, Asthma and Immunology.
    Ann Allergy Asthma Immunol. 2022 May 22. pii: S1081-1206(22)00449.
    PubMed    


  163. HUDDLESTON CM, Slaven JE, Weist AD, Krupp NL, et al
    Increased Healthcare Utilization in Moderate to Severe Asthma Patients Due to Frequent Preferred Medication Changes.
    Ann Allergy Asthma Immunol. 2022 May 21. pii: S1081-1206(22)00448.
    PubMed    


  164. SHERREY J, Biggs S, Dorrian J, Martin J, et al
    Allergic disease, sleep problems and psychological distress in children recruited from the general community.
    Ann Allergy Asthma Immunol. 2022 May 19. pii: S1081-1206(22)00409.
    PubMed     Abstract available


  165. MENDY A, Mersha TB
    Comorbidities in Childhood-onset and Adult-Onset Asthma.
    Ann Allergy Asthma Immunol. 2022 May 17. pii: S1081-1206(22)00410.
    PubMed     Abstract available


  166. POLINSKI KJ, Bell GA, Trinh MH, Sundaram R, et al
    Maternal obesity, gestational weight gain and offspring asthma and atopy.
    Ann Allergy Asthma Immunol. 2022 May 9. pii: S1081-1206(22)00397.
    PubMed     Abstract available


  167. WILSON K, Gebretsadik T, Adgent MA, Loftus C, et al
    The association between duration of breastfeeding and childhood asthma outcomes.
    Ann Allergy Asthma Immunol. 2022 May 9. pii: S1081-1206(22)00400.
    PubMed     Abstract available


  168. YAMANE M, Ohnishi H, Tsuji K, Anabuki K, et al
    Dupilumab-induced peripheral neuropathy in a patient with severe asthma.
    Ann Allergy Asthma Immunol. 2022;128:611.
    PubMed    


  169. GALANT SP, Morphew T, Ehwerhemuepha L
    Reduced exposure to respiratory viral triggers may explain less health care utilization for children with asthma.
    Ann Allergy Asthma Immunol. 2022;128:486-487.
    PubMed    


  170. WHITE AA
    If aspirin-exacerbated respiratory disease treatment is a jigsaw puzzle, where do the aspirin and biologic pieces go?
    Ann Allergy Asthma Immunol. 2022;128:484-485.
    PubMed    


  171. GRAYSON MH
    New! American College of Allergy, Asthma and Immunology Annals fellow-in-training award program.
    Ann Allergy Asthma Immunol. 2022;128:483.
    PubMed    


  172. SPERGEL BL, Ruffner MA, Godwin BC, Liacouras CA, et al
    Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use.
    Ann Allergy Asthma Immunol. 2022;128:589-593.
    PubMed     Abstract available


    April 2022
  173. HASAN ARSHAD S
    Does allergen Immunotherapy for allergic rhinitis prevent asthma?
    Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00392.
    PubMed     Abstract available


  174. WONG M, Forno E, Celedon JC
    Asthma: interactions between obesity and other risk factors.
    Ann Allergy Asthma Immunol. 2022 Apr 29. pii: S1081-1206(22)00394.
    PubMed     Abstract available


  175. NIESSEN NM, Fricker M, McDonald VM, Gibson PG, et al
    T2-low: What do we know? - Past, present, and future of biologic therapies in non-eosinophilic asthma.
    Ann Allergy Asthma Immunol. 2022 Apr 26. pii: S1081-1206(22)00342.
    PubMed     Abstract available


  176. CIPRANDI G, Schiavetti I, Cioffi L, Pane M, et al
    The PRObiotics in Pediatric Asthma Management (PROPAM) study: a post-hoc analysis in allergic children.
    Ann Allergy Asthma Immunol. 2022 Apr 26. pii: S1081-1206(22)00391.
    PubMed    


  177. ELDEIRAWI KM, Nyenhuis SM, Huntington-Moskos L, Polivka BJ, et al
    COVID-19 Related Anxiety Is Associated with Uncontrolled Asthma in Adults.
    Ann Allergy Asthma Immunol. 2022 Apr 22. pii: S1081-1206(22)00308.
    PubMed    


  178. WINSLOW A, Keet C
    Preventing Allergies Through the Skin.
    Ann Allergy Asthma Immunol. 2022 Apr 22. pii: S1081-1206(22)00311.
    PubMed     Abstract available


  179. ZHANG H, Xian M, Shi X, Luo T, et al
    Blocking function of allergen-specific IgG, F(ab')2, and Fab antibodies prepared from patients undergoing Dermatophagoides pteronyssinus immunotherapy.
    Ann Allergy Asthma Immunol. 2022 Apr 8. pii: S1081-1206(22)00293.
    PubMed     Abstract available


  180. ALABDULKARIM N, Gai J, Bost J, Pillai D, et al
    Effect of the COVID-19 pandemic on morbidity among children hospitalized for an asthma exacerbation.
    Ann Allergy Asthma Immunol. 2022 Apr 7. pii: S1081-1206(22)00294.
    PubMed     Abstract available


  181. CROPPER KJ, Davis BE, Cockcroft DW
    Effect of daily tiotropium on allergen-induced early asthmatic responses and airway inflammation.
    Ann Allergy Asthma Immunol. 2022 Apr 5. pii: S1081-1206(22)00296.
    PubMed    


  182. OPPENHEIMER J, Leung DYM
    Asthma 2022-moving toward precision medicine.
    Ann Allergy Asthma Immunol. 2022;128:343.
    PubMed    


  183. BORISH L
    Rethinking the central role of mast cells in virally-mediated asthma exacerbations.
    Ann Allergy Asthma Immunol. 2022 Apr 1. pii: S1081-1206(22)00288.
    PubMed    


  184. MISS OZUNA L, Ryan T, Bensko JC, Laidlaw TM, et al
    Dupilumab-associated arthralgia in patients with aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2022;128:469-472.
    PubMed    


    March 2022
  185. HOWELL D, Rogers L, Kasarskis A, Twyman K, et al
    Comparison and Validation of Algorithms for Asthma Diagnosis in an Electronic Medical Record System.
    Ann Allergy Asthma Immunol. 2022 Mar 30. pii: S1081-1206(22)00285.
    PubMed     Abstract available


  186. MACDONALD M, Chang WC, Martin LJ, Hershey GKK, et al
    The Pediatric Asthma Risk Score (PARS): more does not mean better.
    Ann Allergy Asthma Immunol. 2022 Mar 29. pii: S1081-1206(22)00284.
    PubMed    


  187. KIMURA H, Shimizu K, Tanabe N, Makita H, et al
    Further evidence for association of YKL-40 with severe asthma airway remodeling.
    Ann Allergy Asthma Immunol. 2022 Mar 24. pii: S1081-1206(22)00207.
    PubMed     Abstract available


  188. LUDWIG A, Brehm C, Fung C, Jia S, et al
    Asthma and COVID-19 related outcomes in hospitalized patients: A single center experience.
    Ann Allergy Asthma Immunol. 2022 Mar 24. pii: S1081-1206(22)00208.
    PubMed     Abstract available


  189. OPPENHEIMER J, Hoyte FCL, Phipatanakul W, Silver J, et al
    Allergic and eosinophilic asthma in the era of biomarkers and biologics: similarities, differences and misconceptions.
    Ann Allergy Asthma Immunol. 2022 Mar 7. pii: S1081-1206(22)00170.
    PubMed     Abstract available


  190. ADEJUMO I, Patel M, McKeever TM, Shaw DE, et al
    Does inhaler technology improve adherence and asthma control? A pilot randomised controlled trial.
    Ann Allergy Asthma Immunol. 2022 Mar 4. pii: S1081-1206(22)00169.
    PubMed    


  191. WANG Y, Guo D, Chen X, Wang S, et al
    Trends in asthma among adults in the United States, NHANES 2005-2018.
    Ann Allergy Asthma Immunol. 2022 Mar 4. pii: S1081-1206(22)00168.
    PubMed    


  192. PATEL P, Bensko JC, Bhattacharyya N, Laidlaw TM, et al
    Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2022;128:326-328.
    PubMed    


    February 2022
  193. KOINIS-MITCHELL D, D'Angelo C, Dunsiger S, McQuaid E, et al
    Effects of COVID-19 Pandemic on Children, Adolescents and Young Adults with Asthma in Rhode Island: Patterns in Emergency Department Utilization with Geospatial Mapping.
    Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00120.
    PubMed     Abstract available


  194. MACIAG MC, Phipatanakul W
    Update on Indoor Allergens and Their Impact on Pediatric Asthma.
    Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00119.
    PubMed     Abstract available


  195. RAMEY OL, Silva Almodovar A, Nahata MC
    Medication Adherence in Medicare Enrolled Older Adults with Asthma Before and During the COVID-19 Pandemic.
    Ann Allergy Asthma Immunol. 2022 Feb 25. pii: S1081-1206(22)00121.
    PubMed     Abstract available


  196. MELHORN DJ, Howell DI, Pavord PID
    Should we apply a treatable traits approach to asthma care?
    Ann Allergy Asthma Immunol. 2022 Feb 13. pii: S1081-1206(22)00098.
    PubMed     Abstract available


  197. SEHAYEK D, Gold MS, Gabrielli S, Abrams EM, et al
    Seafood-Induced Anaphylaxis in Children Presenting to Canadian Emergency Departments: Rates, Clinical Presentation and Management.
    Ann Allergy Asthma Immunol. 2022 Feb 13. pii: S1081-1206(22)00097.
    PubMed     Abstract available


  198. ENG V, Moreno GP, Chang J, Liebhaber M, et al
    A Pediatric Asthma Camp Experience during the COVID-19 Pandemic.
    Ann Allergy Asthma Immunol. 2022 Feb 4. pii: S1081-1206(22)00087.
    PubMed    


  199. MULLUR J, Steger CM, Gakpo D, Bensko JC, et al
    Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease: Efficacy, tolerability, and patient experience.
    Ann Allergy Asthma Immunol. 2022 Feb 4. pii: S1081-1206(22)00090.
    PubMed     Abstract available


  200. CHIPPS BE, Murphy KR, Wise RA, McCann WA, et al
    Assessing Construct Validity of the Asthma Impairment and Risk Questionnaire Using a 3-month Exacerbation Recall.
    Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00081.
    PubMed     Abstract available


  201. GUILBERT TW, Biagini JM, Ramsey RR, Keidel K, et al
    Treatment by Biomarker-Informed Endotype Versus Guideline Care in Children with Difficult to Treat Asthma.
    Ann Allergy Asthma Immunol. 2022 Feb 2. pii: S1081-1206(22)00076.
    PubMed    


    January 2022
  202. STOUT S, Murphy H, Pandya A, Yeh HW, et al
    The Effect of COVID-19 on Asthma Visits.
    Ann Allergy Asthma Immunol. 2022 Jan 28. pii: S1081-1206(22)00048.
    PubMed    


  203. GENG B, Dixon AE, Ko J, Janampally P, et al
    Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma.
    Ann Allergy Asthma Immunol. 2022 Jan 28. pii: S1081-1206(22)00045.
    PubMed     Abstract available


  204. WANG E, Wechsler ME
    A Rational Approach to Compare and Select Biologic Therapeutics in Asthma.
    Ann Allergy Asthma Immunol. 2022 Jan 27. pii: S1081-1206(22)00046.
    PubMed     Abstract available


  205. POPOV TA, Hristova D, Kralimarkova TZ, Mustakov TB, et al
    Time course of disease characteristics in subjects with severe allergic asthma starting treatment with omalizumab.
    Ann Allergy Asthma Immunol. 2022 Jan 24. pii: S1081-1206(22)00024.
    PubMed    


  206. DROUIN O, Smyrnova A, Betinjane N, Ducharme FM, et al
    Adherence to inhaled corticosteroids prescribed once- vs twice-daily in children with asthma.
    Ann Allergy Asthma Immunol. 2022 Jan 22. pii: S1081-1206(22)00022.
    PubMed     Abstract available


  207. MUISER S, Gosens R, van den Berge M, Kerstjens HAM, et al
    Understanding the role of long-acting muscarinic antagonists in asthma treatment.
    Ann Allergy Asthma Immunol. 2022 Jan 21. pii: S1081-1206(22)00017.
    PubMed     Abstract available


  208. ESCHENBACHER W, Kim M, Mattos J, Lawrence M, et al
    Activation of platelet-adherent basophils in chronic rhinosinusitis with alcohol hypersensitivity.
    Ann Allergy Asthma Immunol. 2022 Jan 18. pii: S1081-1206(22)00014.
    PubMed     Abstract available


  209. FENG X, Lawrence MG, Payne SC, Mattos J, et al
    Lower viral loads in rhinovirus-challenged allergic subjects despite reduced innate immunity.
    Ann Allergy Asthma Immunol. 2022 Jan 12. pii: S1081-1206(22)00010.
    PubMed     Abstract available


  210. VISWAM D, Mansur AH
    Mode of onset and triggers of severe asthma; the severe asthma clinic perspective.
    Ann Allergy Asthma Immunol. 2022 Jan 11. pii: S1081-1206(22)00008.
    PubMed    


  211. WONG M, Han YY, Rosser F, Acosta-Perez E, et al
    Persistent overweight or obesity, lung function, and asthma exacerbations in Puerto Rican Youth.
    Ann Allergy Asthma Immunol. 2022 Jan 8. pii: S1081-1206(22)00005.
    PubMed     Abstract available


  212. LOBATO M, Gaspar-Marques J, Carreiro-Martins P, Pinto PL, et al
    Secondary adrenal suppression related to high doses of inhaled corticosteroids in severe asthma patients.
    Ann Allergy Asthma Immunol. 2022 Jan 7. pii: S1081-1206(22)00002.
    PubMed    


  213. BACHARIER LB
    Asthma Guidelines: Where to next?: A Perspective for Annals of Allergy, Asthma & Immunology.
    Ann Allergy Asthma Immunol. 2022 Jan 5. pii: S1081-1206(21)01342.
    PubMed    


  214. WANG E, Zahid S, Moudgal AN, Demaestri S, et al
    Intimate Partner Violence and Asthma in Pediatric and Adult Populations: A Systematic Review.
    Ann Allergy Asthma Immunol. 2022 Jan 4. pii: S1081-1206(21)01343.
    PubMed     Abstract available


  215. LAWRENCE MG, Teague WG, Feng X, Welch C, et al
    Interleukin-5 receptor alpha (CD125) expression on human blood and lung neutrophils.
    Ann Allergy Asthma Immunol. 2022;128:53-60.
    PubMed     Abstract available


    December 2021
  216. BURROWS AG, Ellis AK
    Psychological Impacts of COVID-19 on people with Asthma, Allergic Rhinitis and Food Allergy.
    Ann Allergy Asthma Immunol. 2021 Dec 28. pii: S1081-1206(21)01310.
    PubMed    


  217. FISCHELL SZ, Fischell JM, Olexa G, Callahan C, et al
    Impact of COVID-19 pandemic on frequency and severity of asthma exacerbations in an inner-city population.
    Ann Allergy Asthma Immunol. 2021 Dec 16. pii: S1081-1206(21)01308.
    PubMed    


    November 2021
  218. CORREN J, Silver J, Molfino NA, Bogart M, et al
    A real-world study of ICS use in patients with severe eosinophilic asthma treated with mepolizumab.
    Ann Allergy Asthma Immunol. 2021 Nov 10. pii: S1081-1206(21)01219.
    PubMed     Abstract available


  219. LU MA, Eckmann T, Ruvalcaba E, McQuaid EL, et al
    Family Management of Asthma in Head Start Preschool Children.
    Ann Allergy Asthma Immunol. 2021 Nov 10. pii: S1081-1206(21)01217.
    PubMed     Abstract available


  220. CARR TF
    Treatment approaches for the patient with T2 low asthma.
    Ann Allergy Asthma Immunol. 2021;127:530-535.
    PubMed     Abstract available


  221. OPPENHEIMER JJ, Leung DYM
    Asthma, in quest of optimizing care.
    Ann Allergy Asthma Immunol. 2021;127:517.
    PubMed    


  222. LEVERONE N, Tran S, Barry J, Akuthota P, et al
    Diagnoses associated with peripheral blood eosinophilia: A 5-year review.
    Ann Allergy Asthma Immunol. 2021;127:597-598.
    PubMed    


    October 2021
  223. LAFORCE C, Chipps BE, Albers FC, Reilly L, et al
    Albuterol/budesonide for the treatment of exercise-induced bronchoconstriction in patients with asthma: the TYREE study.
    Ann Allergy Asthma Immunol. 2021 Oct 23. pii: S1081-1206(21)01169.
    PubMed     Abstract available


  224. GRANT T, Croce E, Matsui E
    Asthma and the Social Determinants of Health.
    Ann Allergy Asthma Immunol. 2021 Oct 18. pii: S1081-1206(21)01132.
    PubMed     Abstract available


  225. AVDEEV SN, Pozdnakova AA, Gaynitdinova VV, Chikina SY, et al
    Asthma in older adults with severe COVID-19: clinical outcomes and predictors of mortality.
    Ann Allergy Asthma Immunol. 2021 Oct 17. pii: S1081-1206(21)01163.
    PubMed    


  226. HOSSAIN R, Zhao F, Michenkova M, Kaelber D, et al
    Trends in racial disparities in asthma emergency department utilization during COVID-19.
    Ann Allergy Asthma Immunol. 2021 Oct 12. pii: S1081-1206(21)01159.
    PubMed    


  227. TORRE AB, Dasgupta R, Eldeirawi KM, Nyenhuis SM, et al
    Positive associations of pollutants and aeroallergens with allergic rhinitis in adults with asthma.
    Ann Allergy Asthma Immunol. 2021 Oct 11. pii: S1081-1206(21)01157.
    PubMed    


  228. STAMPFLI M, Frei R, Divaret-Chauveau A, Schmausser-Hechfellner E, et al
    Inverse associations between food diversity in the 2(nd) year of life and allergic diseases.
    Ann Allergy Asthma Immunol. 2021 Oct 11. pii: S1081-1206(21)01154.
    PubMed     Abstract available


  229. BLEECKER ER, Gandhi H, Gilbert I, Murphy KR, et al
    Mapping Geographic Variability of Severe Uncontrolled Asthma in the United States: Management Implications.
    Ann Allergy Asthma Immunol. 2021 Oct 7. pii: S1081-1206(21)01125.
    PubMed     Abstract available


    September 2021
  230. LAM RW, Inselman JW, Jeffery MM, Maddux JT, et al
    National decline in asthma exacerbations in US during COVID19 pandemic.
    Ann Allergy Asthma Immunol. 2021 Sep 25. pii: S1081-1206(21)01113.
    PubMed    


  231. SACO T, Ugalde IC, Cardet JC, Casale TB, et al
    Strategies for choosing a biologic for your patient with allergy or asthma.
    Ann Allergy Asthma Immunol. 2021 Sep 23. pii: S1081-1206(21)01035.
    PubMed     Abstract available


    July 2021
  232. BALL L, Velasquez SA, Jammal OMA, White AA, et al
    Atypical Eosinophilic Granulomatosis with Polyangiitis with Spontaneous Aspirin Reactivity and IgE Mediated Anaphylaxis.
    Ann Allergy Asthma Immunol. 2021 Jul 14. pii: S1081-1206(21)00502.
    PubMed    


  233. UDOKO M, De Keyser H, Szefler SJ
    Should Asthmatic Children Simply be Treated as Little Adults?
    Ann Allergy Asthma Immunol. 2021 Jul 11. pii: S1081-1206(21)00498.
    PubMed    


  234. FINEMAN S, Lee G, Hernandez-Truillo V, Chipps BE, et al
    From the Pages of Allergy Watch.
    Ann Allergy Asthma Immunol. 2021 Jul 8. pii: S1081-1206(21)00490.
    PubMed    


    May 2021
  235. ABRAMS EM, Greenhawt M, Shaker M, Kosowan L, et al
    Primary Care Provider-Reported Prevalence of Vaccine and Polyethylene-Glycol Allergy in Canada.
    Ann Allergy Asthma Immunol. 2021 May 15. pii: S1081-1206(21)00357.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Asthma is free of charge.